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Long noncoding RNAs (lncRNAs) have been detected in nearly every cell type and found to be fundamentally
involved in many biological processes. The characterization of lncRNAs has immense potential to advance our
comprehensive understanding of cellular processes and gene regulation, along with implications for the treatment
of human disease. The recent ENCODE (Encyclopedia of DNA Elements) study reported 9,640 lncRNA loci in the
human genome, which corresponds to around half the number of protein-coding genes. Because of this sheer
number and their functional diversity, it is crucial to identify a pool of potentially relevant lncRNAs early on in a
given study. In this review, we evaluate the methods for isolating lncRNAs by immunoprecipitation and review the
advantages, disadvantages, and applications of three widely used approaches – microarray, tiling array, and
RNA-seq – for identifying lncRNAs involved in gene regulation. We also look at ways in which data from publicly
available databases such as ENCODE can support the study of lncRNAs.
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Long noncoding RNA (lncRNA) is operationally defined as
RNA longer than 200 bases that does not encode mRNA,
rRNA or tRNA [1,2]. Although several lncRNAs have been
sporadically identified and characterized in the past 20 years,
genome-wide identification of lncRNAs has only recently
become possible with the advent of high-throughput se-
quencing technologies of cDNA (RNA-seq). Evidence that
this field is gaining momentum can be seen in the most
recent report of the ENCODE (Encyclopedia of DNA
Elements) project published in September 2012, which
described 9,640 lncRNA loci in comparison to 20,687
protein-coding genes in 15 human cell lines [3-5]. This
ratio of lncRNAs and protein-coding genes underscores
the potential magnitude and diversity of the biological
effects mediated by lncRNAs. Indeed, despite the fact that
only about 100 lncRNAs have been functionally character-
ized to date [4], it has become clear that lncRNAs are
involved in almost every aspect of cellular and molecular
biology. LncRNAs control cell differentiation, develop-
ment, cancer progression, and cell metabolism, among* Correspondence: kikyo001@umn.edu
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reproduction in any medium, provided the orother cell functions. At the gene expression level,
lncRNAs regulate all processes of RNA metabolism in-
cluding chromatin modification, transcription, splicing,
RNA transport, and translation. LncRNAs themselves are
transcribed from intergenic regions, exons, introns, and
their overlapping regions (Figure 1A and 1B). At the
mechanistic level, lncRNAs serve as “scaffolds” providing
platforms to assemble RNA-protein complexes, “guides”
to recruit RNAprotein complexes to target genes, and
“decoys” by binding to and sequestering regulatory pro-
teins away from their target DNA sequences [1,2]. Given
the recent appreciation for the biological importance of
lncRNAs, it is now clear that, regardless of the research
project or field, one needs to ask whether lncRNAs are es-
sential mechanistic components of the biological process
under consideration. The first step to addressing this
question is to identify lncRNAs that are potentially rele-
vant to the research field. The current review article pro-
vides an overview of four widely used approaches to
identify lncRNAs involved in gene regulation – immuno-
precipitation of RNA and chromatin, microarray, tiling
array, and RNA-seq – and discusses the advantages and
disadvantages of each approach. These approaches, which
are not mutually exclusive and are often combined in a
single study, have been successfully used to identifyl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Figure 1 Overview of lncRNA populations depending on the
locations on the genome. LncRNAs can be categorized into
subgroups of intergenic, exonic, intronic, and overlapping according
to where they are found relative to nearby protein-coding genes.
(A) Proportion of lncRNA subgroups [3]. (B) Location of each type
of lncRNA.
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lation, which has been the main area of functional studies
of lncRNAs; however, lncRNAs are also involved in the
organization of cellular structure and subcellular orga-
nelles. For further information on these and other aspects
of lncRNA biology, readers are referred to the following
recent reviews: [1,2,6-11].
Collection of lncRNAs by immunoprecipitation
The first challenge in studying lncRNAs is how to collect
RNA pools that potentially contain lncRNAs of interest.
One can prepare RNA pools by simply isolating total RNA
from cells or tissues in an unbiased manner; however,
immunoprecipitation-based approaches are also com-
monly used to enrich lncRNAs associated with specific
proteins. RNA immunoprecipitation (RIP) can be per-
formed with or without cross-linking whole cellular
components before making cell extracts. Without cross-
linking, one can isolate lncRNA complexes already
existing in soluble form and those that can be readily
dissociated from chromatin. Zhao et al. used RIP of
polycomb repressive complex 2 (PRC2), a key regulator
of epigenetic silencing, without cross-linking and co-
immunoprecipitated the lncRNA Xist, which was ampli-
fied by RT-PCR [13]. Using the same procedure, they
discovered co-immunoprecipitation of the novel lncRNARepA, which is transcribed within the Xist locus [13].
To identify unknown lncRNAs by RIP, the co-
immunoprecipitated RNA pool can be applied to micro-
array analyses or RNA-seq, as described later [19,23,28]. If
one needs to exclude the possibility of indirect interactions
between lncRNAs and proteins through their binding to
neighboring DNA sequences, the immunoprecipitated
materials can be treated with RNase H (digests RNA in
RNA-DNA hybrids) and DNase I prior to elution of co-
immunoprecipated molecules. As a control, treatment
with RNase A, RNase I (both digest single-stranded RNA),
and/or RNase V1 (double-stranded RNA) should abolish
the co-immunoprecipitation [22,28].
There are several RIP techniques that employ cross-
linking. RIP is sometimes performed after ultraviolet
(UV) irradiation of cells, which cross-links RNA and
protein (pyrimidines and Cys, Lys, Phe, Trp, and Tyr)
but not protein and protein [30]. This unique feature
allows for the recovery of lncRNAs that directly interact
with the immunoprecipitated protein. Taking advantage
of this high specificity, UV cross-linking is used to iden-
tify the domains within an RNA molecule responsible
for the interaction with the protein partner. For instance,
Zhao et al. irradiated cells with 254 nm UV prior to
making cell extracts and immunoprecipitated PRC2 to
identify directly associated lncRNAs [28].
A related variation is called CLIP (cross-linking and
immunoprecipitation), which was designed to isolate a
protein-interacting domain within a given RNA molecule
after using a stringent wash to reduce non-specific binding
[30]. In a typical CLIP experiment, extracts are made from
cells after UV-irradiation and treated with RNase to retain
only the RNA region protected by the interacting protein.
The partially digested RNA pool is then tagged with a 3’
linker and also radio-labeled. After purification of the pro-
tein with immunoprecipitation, SDS gel electrophoresis,
autoradiography, and band excision, the bound protein is
removed by proteinase K treatment. The exposed RNA is
tagged with a 5’ linker and PCR-amplified to identify the
sequence. CLIP was successfully used to immunoprecipi-
tate five intronic lncRNAs directly associated with the
PRC2 complex [27].
Cross-linking with UV or formaldehyde followed by
fragmentation of chromatin is used to immunoprecipi-
tate RNA-chromatin complexes (RNA-chromatin immu-
noprecipitation or RNA-ChIP) [12,14,22]. While this
approach potentially detects false-positive interactions
between RNA and protein through DNA as described
above, it can be useful to identify lncRNAs that bind to
specifically modified histones which require chromatin
fragmentation for extraction.
For any of these immunoprecipitation-based approaches,
specificity and affinity of the antibodies are decisive factors
for the success or failure of the projects. While the
Table 1 Examples of lncRNAs discovered with various approaches described in the text
lncRNA name Types of RNA lncRNA identification methods* Reference
ANRIL RNA-ChIP (UV cross-linking) and CLIP RT-PCR [12]
RepA RIP (no cross-linking) Northern blotting [13]
TRE-1, -2 and -3 RNA-ChIP (cross-linked with formaldehyde) RT-PCR [14]
Xist RIP (no cross-linking) RT-PCR [13]
LincRNA-EPS Polyadenylated RNA Microarrays of 10,802 lncRNAs and RNA-seq [15]
lincRNA-SFMBT2, lincRNA-RoR,
and lincRNA-VLDLR
Total RNA Microarrays of 900 lincRNAs [16]
lncRNA_ES1, ES2 and ES3 Total RNA Microarrays of 6,671 lncRNAs [17]
ncRNA-a1-7 Polyadenylated RNA Microarrays of 3,019 lncRNAs [18]
HOTAIR Polyadenylated RNA Tiling arrays of 39 HOX genes [19]
RIP (no cross-linking) Validation with RT-PCR
HOTAIRM1 Polyadenylated RNA Tiling arrays of HOXA genes [20]
lincRNA-p21 Polyadenylated RNA Tiling arrays of 400 lincRNAs [21]
Mistral RNA-ChIP (no cross-linking) Tiling arrays of chromosomes 6, 8 and 16 [22]
300 lincRNAs RIP (no cross-linking) Tiling arrays of 900 lincRNAs [23]
1,600 lincRNAs Polyadenylated RNA Tiling arrays of 350 K4-K36 domains [24]
ANCR Polyadenylated RNA RNA-seq [25]
BANCR Polyadenylated RNA RNA-seq [26]
5 lncRNAs CLIP RNA-seq [27]
216 lincRNAs RIP (no cross-linking) RNA-seq [28]
RIP (UV cross-linking) Validation with RT-PCR
>8,000 lncRNAs Polyadenylated RNA Analysis of existing RNA-seq data [29]
* LncRNAs are categorized based on the methods of their discovery: gene-specific approaches (RT-PCR and Northern blotting), microarrays, tiling arrays and
RNA-seq.
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ing only one band in western blotting, the antibodies may
react with other proteins when detergents are used at a low
concentration during immunoprecipitation. One solution
to address the specificity issue is to use multiple antibodies
against the same protein and select reproducibly co-
precipitated lncRNAs for further study. Similarly, immuno-
precipitation of several different subunits within a single
protein complex is also an option to identify lncRNAs that
are likely to be genuinely interacting with the complex.
Identification of lncRNAs with microarrays
Microarray-based approaches and RNA-seq are two of
the most commonly used genome-wide screening
methods to identify lncRNAs that might be relevant to
a specific biological question. Although a tiling array
should be included in the microarray section by defi-
nition, it will be discussed separately in the next section
as it is frequently used for different purposes. Because
traditional microarrays can only detect the presence or ab-
sence of known lncRNAs in an RNA pool, they are inhe-
rently incapable of identifying novel lncRNAs. Inability of
distinguishing different splicing variants is another disad-
vantage of microarrays unless probes encompassing exon-exon junctions are present on the chip. However, given
the cost and complexity of the analysis of RNA-seq data,
microarray remains the first choice in many applications
[15-18]. In particular, since the identification of 9,640
lncRNA loci as part of the ENCODE project, the compre-
hensiveness of microarrays for human lncRNAs has been
drastically improved.
Data generation with microarrays is relatively easy
compared to the subsequent step of selecting potentially
important lncRNAs from the positive probes on the
arrays because the majority of identified lncRNAs re-
main uncharacterized. Here, the work by Loewer et al.
serves as an exemplary case study of how to narrow
down lncRNA candidates relevant to one’s interest, in
this case, association with pluripotency [16]. Loewer and
colleagues designed a microarray containing 900 long
intergenic noncoding RNAs (lincRNAs) and hybridized
them with total RNA prepared from several different cell
lines to identify induced pluripotent stem cell-specific
lincRNAs. In their case, the selection criteria included
the genomic location (close to the binding sites of pluri-
potency transcription factors), nearby presence of epi-
genetic markers for active transcription, behavior of the
lincRNA level during differentiation, and consequence of
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acquisition of pluripotency. Similar concepts can be
widely applied to selecting lncRNAs in other contexts.Identification of lncRNAs with tiling arrays
Unlike traditional microarrays, DNA tiling arrays con-
tain oligonucleotide probes encompassing an entire
length of a defined DNA region. Resolution of the
hybridized genomic DNA sequence can be adjusted by
changing the length of the overlapping sequences be-
tween two neighboring probes. A major advantage of
using tiling arrays is their capacity to identify novel
lncRNAs in a selected DNA region without prior know-
ledge of their precise locations within the region. The
DNA region can be defined by the residing genes of
interest. For instance, Rinn et al. focused on lncRNAs
expressed in the region of the human HOX genes and
compared skin fibroblasts isolated from different ana-
tomical regions of the body [19]. They printed 400,000
probes of 50 bases in length with each probe overlap-
ping the next one by 45 bases to cover all four human
HOX gene clusters. This configuration allowed for the
identification of hybridized DNA sequences at 5-base
resolution. Polyadenylated RNAs prepared from fibro-
blasts were then hybridized to the tiling arrays, resulting
in the discovery of the lncRNA HOTAIR transcribed
from an intergenic region within the HOXC cluster. A
similar HOX tiling array was used to identify lncRNAs
specifically expressed in metastatic breast carcinoma
[31]. The lncRNA HOTAIRM1 was discovered in the
intergenic region between the HOXA1 and HOXA2
genes with commercially available tiling arrays covering
the human HOXA gene cluster [20].
The DNA regions of interest can also be determined
by the unique epigenetic features of the regions. Actively
transcribed genes are enriched with trimethylation of ly-
sine 4 on histone H3 at their promoters and trimethyla-
tion of lysine 36 on histone H3 in their coding regions
[32], which are collectively called K4-K36 domains. Ta-
king advantage of this knowledge, Guttman et al. pre-
pared DNA tiling arrays with 2.1 million oligonucleotide
probes representing 350 K3-K36 domains and hybridized
them with polyadenylated RNA to identify 1,600 mouse
lincRNAs [24]. A similar tiling array was used to identify
300 lincRNAs in human cells [23]. Thus, the tiling array
approach is highly useful to comprehensively detect any
transcripts, including lncRNAs, transcribed from a
defined DNA region at a high resolution in an unbiased
manner. However, unless the target region is reasonably
limited, a potential drawback of the tiling array approach
is its high cost. Tiling arrays generally need to be
custom-made to meet diverse needs, which further raises
the cost and slows down manufacturing the arrays.Identification of lncRNAs with RNA-seq
RNA-seq is a powerful tool based on the principles of
next-generation sequencing that can be applied to the de-
tection and quantification of lncRNAs. Some advantages
of using RNA-seq over a microarrary-based approach are
that RNA-seq works on a genome-wide scale at single nu-
cleotide resolution and is not limited to detecting already
known sequences. Thus, it can be used to discover pre-
viously unknown lncRNAs in an unbiased manner [33].
However, the time and cost related to the downstream
analysis of the data generated by RNA-seq is a consi-
derable disadvantage of this approach.
Before beginning RNA-seq, one must decide whether to
use total RNA or polyadenylated RNA. The presence of
rRNA (around 80-85% of total RNA) and tRNA (15%)
[34,35] can drastically reduce the diversity of a cDNA li-
brary during amplification of cDNAs. Polyadenylated
RNA is frequently used for RNA-seq to avoid this prob-
lem. However, given the prevalence of non-polyadenylated
lncRNA in the genome (around 40% of total lncRNAs),
the disadvantage of losing this fraction is not negligible
[36]. One solution to this problem is to use commercially
available kits to remove rRNA from total RNA without
losing non-polyadenylated RNA.
After sequencing, the generated reads are typically
aligned to the UCSC mouse mm10 or human hg19
reference genomes using software programs such as
the short-read mappers Bowtie 2 [37] and Burrows-
Wheeler Aligner [38], and the splice-junction identifier
TopHat [39]. Next, the reads are used to assemble a
transcriptome and discover previously unannotated
transcripts with programs such as Cufflinks [40], which
relies on a reference annotation database, or Scripture,
which builds the transcriptome ab initio [41]. From
here, novel lncRNAs can be identified by excluding
protein-coding transcripts and annotated lncRNAs
based on the databases of RefSeq, ENCODE, and
FANTOM (Functional Annotation of the Mammalian
Genome) [42], as well as the two databases of experi-
mentally verified lncRNAs generated by the Mattick
lab: lncRNAdb [43] and NRED (Noncoding RNA Ex-
pression Database) [44].
Novel lncRNAs often undergo further scrutiny to verify
that they are not transcriptional noise and that they indeed
do not encode proteins. For instance, if the candidate is
located within a K4-K36 domain and enriched with RNA
polymerase II binding sites and DNase I hypersensitivity
sites (a sign of open chromatin) as detected with the EN-
CODE data, the candidate is likely to be a product of ac-
tive transcription [25,26,29]. The protein-coding potential
of a candidate lncRNA can be evaluated with the Coding
Potential Calculator (CPC) algorithm and other programs
[45,46]. However, this is not a straightforward task as
detailed in a recent review article [47].
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The recent identification of the genome-wide human
lncRNA loci by the ENCODE project is undoubtedly a
milestone toward the long-term goal of understanding the
functional significance of lncRNAs in many biological
phenomena. Applications of microarrays containing these
probes will certainly lower the threshold of launching new
studies of lncRNAs. However, the use of tiling arrays and
RNA-seq will continue to be required to identify splicing
variants and tissue-specific lncRNAs. In addition, because
of the low conservation of lncRNA sequences across spe-
cies, the use of these approaches in new species will remain
necessary until their ENCODE equivalents become pub-
licly available. Furthermore, we expect that additional
technological innovations geared toward studying lncRNAs
will continuously emerge to support the rapid develop-
ment of this fascinating research field.
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